101 related articles for article (PubMed ID: 7679776)
1. Human immunodeficiency virus. Playing chess with reverse transcriptase.
Richman DD
Nature; 1993 Feb; 361(6413):588-9. PubMed ID: 7679776
[No Abstract] [Full Text] [Related]
2. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development.
de Clercq E
Med Res Rev; 1996 Mar; 16(2):125-57. PubMed ID: 8656777
[No Abstract] [Full Text] [Related]
3. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
[TBL] [Abstract][Full Text] [Related]
4. [Interaction of primers with mutant forms of human immunodeficiency virus reverse transcriptase].
Zakharova OD; Suturina OA; Gudima SO; Pokholok DK; Iamkovoĭ VI; Kochetkov SN; Nevinskiĭ GA
Mol Biol (Mosk); 1996; 30(1):231-40. PubMed ID: 8714140
[No Abstract] [Full Text] [Related]
5. Expression of the human immunodeficiency virus in Escherichia coli: chemotherapy.
Hizi A; Hughes SH
Important Adv Oncol; 1989; ():29-39. PubMed ID: 2468601
[No Abstract] [Full Text] [Related]
6. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
[TBL] [Abstract][Full Text] [Related]
7. Potential animal model for AIDS.
Science; 1995 Sep; 269(5232):1819, 1821. PubMed ID: 7569914
[No Abstract] [Full Text] [Related]
8. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
[TBL] [Abstract][Full Text] [Related]
10. Forensic evidence by DNA sequencing.
Albert J; Wahlberg J; Uhlén M
Nature; 1993 Feb; 361(6413):595-6. PubMed ID: 7679777
[No Abstract] [Full Text] [Related]
11. HIV and multidrug resistance.
Emini EA; Graham DJ; Gotlib L; Condra JH; Byrnes VW; Schleif WA
Nature; 1993 Aug; 364(6439):679. PubMed ID: 7689173
[No Abstract] [Full Text] [Related]
12. [Highly specific inhibitors of human immunodeficiency virus type I that are particularly targeted at the reverse transcriptase].
de Clercq E; Snoeck R
Pathol Biol (Paris); 1993 Mar; 41(3):230-6. PubMed ID: 7687340
[No Abstract] [Full Text] [Related]
13. HIV-1 error revealed.
Chow YK; Hirsch MS; Kaplan JC; D'Aquila RT
Nature; 1993 Aug; 364(6439):679. PubMed ID: 7689174
[No Abstract] [Full Text] [Related]
14. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
Larder BA; Kellam P; Kemp SD
Nature; 1993 Sep; 365(6445):451-3. PubMed ID: 7692302
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
Debyser Z; De Vreese K; Knops-Gerrits PP; Baekelandt V; Bhikhabhai R; Strandberg B; Pauwels R; Anné J; Desmyter J; De Clercq E
Mol Pharmacol; 1993 Apr; 43(4):521-6. PubMed ID: 7682649
[TBL] [Abstract][Full Text] [Related]
16. Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.
Larder BA
J Gen Virol; 1994 May; 75 ( Pt 5)():951-7. PubMed ID: 7513745
[No Abstract] [Full Text] [Related]
17. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
[No Abstract] [Full Text] [Related]
19. Nucleoside-analog resistance mutations in HIV-1 reverse transcriptase and their influence on polymerase fidelity and viral mutation rates.
Rezende LF; Prasad VR
Int J Biochem Cell Biol; 2004 Sep; 36(9):1716-34. PubMed ID: 15183340
[TBL] [Abstract][Full Text] [Related]
20. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
